Medicine

Accelerating ASO treatments from growth to implementation

.Completing interests.R.S., M.S., H.G. and A.A.R. are organizers of the 1M1M campaign. H.G. and A.A.R. are actually board of directors members as well as R.S., M.S. and A.A.R. are actually participants of the scientific advisory committee of N1C. A.A.R. makes known employment by LUMC, which has licenses on exon-skipping technology, several of which has been actually certified to BioMarin as well as consequently sublicensed to Sarepta. As co-inventor of some of these patents, A.A.R. was actually entitled to an allotment of royalties. A.A.R. even more divulges functioning as ad hoc specialist for PTC Rehabs, Sarepta Rehabs, Regenxbio, Dyne Therapies, Lilly, BioMarin Pharmaceuticals Inc., Eisai, Entrada, Takeda, Splicesense, Galapagos, Sapreme, Italfarmaco and also Astra Zeneca. In the past 5 years, A.A.R. also carried out impromptu speaking to for Alpha Anomeric. A.A.R. likewise discloses membership of the scientific boards of advisers of Eisai, Hybridize Therapeutics, Muteness Rehabs, Sarepta Therapeutics, Sapreme and Mitorx. Before 5 years, A.A.R. was likewise a clinical board of advisers participant for ProQR. Compensation for A.A.R. u00e2 s consulting and also advising activities is actually paid to LUMC. Over the last 5 years, LUMC likewise obtained speaker gratuity coming from PTC Therapeutics, Alnylam Netherlands, Italfarmaco and Pfizer and also funding for arrangement study coming from Sapreme, Eisai, Galapagos, Synaffix and also Alpha Anomeric. Project financing is acquired coming from Sarepta Rehabs and Entrada using unlimited gives. H.G. possesses nothing at all to divulge relative to the subjects covered in this particular document. Over the last 5 years, he has actually additionally gotten consultancy honoraria from UCB. M.S. obtained consultancy gratuity coming from Ionis, UCB, Prevail, Orphazyme, Biogen, Servier, Reata, GenOrph, AviadoBio, Biohaven, Zevra, Lilly and Solaxa in the past 5 years, all irrelevant to the present document. R.S. has absolutely nothing to reveal relative to the topics dealt with in this particular composition. She has actually obtained speaker and/or working as a consultant gratuity or sponsoring payments coming from Abbvie, Bial, STADA as well as Everpharma previously 5 years.

Articles You Can Be Interested In